Cart
sales@molnova.com
AS602868
CAS No. 219773-55-4
AS602868( AS 602868 | SPC 839 )
Catalog No. M13504 CAS No. 219773-55-4
A potent, selective and ATP-competitive inhibitor of IKK2 with IC50 of 60 nM and Ki of 20 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 873 | Get Quote |
|
| 50MG | 1782 | Get Quote |
|
| 100MG | 2250 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameAS602868
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, selective and ATP-competitive inhibitor of IKK2 with IC50 of 60 nM and Ki of 20 nM.
-
DescriptionA potent, selective and ATP-competitive inhibitor of IKK2 with IC50 of 60 nM and Ki of 20 nM, also interfers directly with FLT3 kinase activation; displays no significant inhibitory activity for IKK1 and a large panel of recombinant kinases; prevents TNF-α induction of the antiapoptotic genes coding for c-IAP-2, Bclx, Bfl-1/A1 and Traf-1, induces cell death in Jurkat leukemic T cells.Blood Cancer Phase 1 Discontinued.
-
In Vitro——
-
In Vivo——
-
SynonymsAS 602868 | SPC 839
-
PathwayImmunology/Inflammation
-
TargetIκB kinase (IKK)
-
RecptorIκB kinase (IKK)
-
Research AreaCancer
-
IndicationBlood cancer
Chemical Information
-
CAS Number219773-55-4
-
Formula Weight366.395
-
Molecular FormulaC18H14N4O3S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(C(C)=C1)N(NC2=C3C(OC)=CC=CC3=NC(C4=CC=CS4)=N2)C1=O
-
Chemical Name1-(5-Methoxy-2-thiophen-2-yl-quinazolin-4-ylamino)-3-methyl-pyrrole-2,5-dione
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Frelin C, et al. Oncogene. 2003 Nov 6;22(50):8187-94.
2. Frelin C, et al. Blood. 2005 Jan 15;105(2):804-11.
3. Griessinger E, et al. Leukemia. 2007 May;21(5):877-85.
4. Jourdan M, et al. Br J Haematol. 2007 Jul;138(2):160-8.
molnova catalog
related products
-
Rosiglitazone HCl
Rosiglitazone HCl is a blood glucose-lowering drugs, stimulating insulin secretion by binding to the PPAR receptors in fat cells.
-
BOT-64
BOT-64 is an IKK-2 inhibitor which targets the Ser177 and/or Ser181 residues in the kinase's activation loop domain.BOT-64 is a cell-permeable benzoxathiole compoundBOT-64 inhibits IKKbeta-mediated IkappaBalpha phosphorylation in LPS-activated macrophages, resulting in sequential prevention of downstream events, including proteolytic degradation of IkappaBalpha, DNA binding ability, and transcriptional activity of NF-kappaB.?
-
IKK2-IN-8
IKK2-IN-8 is a potent, selective IKK2 inhibitor with IC50 of 6 nM.
